Version history

{
  "session_id": "sess_sda-2026-04-01-gap-20260401231108_20260412-084542",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n```json\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"P2X7 Receptor-ATP Cascade for Astrocytic Mitochondrial Donation\",\n      \"mechanism\": \"Extracellular ATP from injured neurons activates astrocytic P2X7 receptors, triggering calcium-PKC signaling that upregulates TNT formation and primes mitochondria for transfer to stressed neurons.\",\n      \"target_gene\": \"P2RX7\",\n      \"confidence_score\": 0.65,\n      \"novelty_score\": 0.7,\n      \"feasibility_score\": 0.75,\n      \"impact_score\": 0.8,\n      \"composite_score\": 0.705,\n      \"testable_prediction\": \"P2X7 knockout or antagonist treatment in AD mouse models will reduce astrocyte-neuron TNT formation and worsen neuronal mitochondrial deficits, quantified by TOMM20 puncta analysis.\",\n      \"skeptic_concern\": \"TRIM46 is primarily neuronal; actin nucleation may involve other proteins (Formins, Arp2/3) requiring validation in astrocytes\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"EV-Mediated Mitochondrial Delivery via CD81/Flotillin-1+ Vesicles\",\n      \"mechanism\": \"Stressed astrocytes release CD81+/Flotillin-1+ extracellular vesicles containing functional mitochondria that are internalized by neurons via actin-dependent endocytosis.\",\n      \"target_gene\": \"CD81\",\n      \"confidence_score\": 0.6,\n      \"novelty_score\": 0.6,\n      \"feasibility_score\": 0.7,\n      \"impact_score\": 0.75,\n      \"composite_score\": 0.665,\n      \"testable_prediction\": \"Isolation of CD81+ EVs from astrocyte conditioned medium and coincubation with neurons will show TOMM20+ mitochondrial transfer blocked by dynamin inhibitors.\",\n      \"skeptic_concern\": \"Mitochondrial cargo loading efficiency and targeting specificity for neurons versus other cell types remain undetermined\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"Miro1-Regulated Mitochondrial Priming for Transfer\",\n      \"mechanism\": \"P2X7-mediated calcium influx disinhibits Miro1 from microtubule anchoring, enabling mitochondrial translocation to the astrocytic membrane for subsequent transfer.\",\n      \"target_gene\": \"Miro1 (RHOT1)\",\n      \"confidence_score\": 0.45,\n      \"novelty_score\": 0.65,\n      \"feasibility_score\": 0.6,\n      \"impact_score\": 0.7,\n      \"composite_score\": 0.548,\n      \"testable_prediction\": \"Astrocyte-specific Miro1 knockdown will prevent calcium-induced mitochondrial membrane proximity assessed by TMRM imaging.\",\n      \"skeptic_concern\": \"Miro1 function in astrocytic mitochondrial dynamics is poorly characterized; astrocyte-specific knockout tools needed\"\n    }\n  ],\n  \"consensus_points\": [\n    \"Mitochondrial dysfunction is a central feature of Alzheimer's disease pathology\",\n    \"P2X7 receptor is a valid druggable target already in clinical pipelines\",\n    \"Astrocytes can transfer functional mitochondria to neurons via direct contact (TNTs) and EV pathways\"\n  ],\n  \"dissent_points\": [\n    \"TRIM46 involvement is contested—theorist proposes it but skeptic notes its primarily neuronal expression; alternative actin regulators (Formins, Arp2/3) may mediate TNT formation in astrocytes\"\n  ],\n  \"debate_summary\": \"The debate converges on P2X7-ATP signaling as the most translationally viable entry point, with expert endorsement of existing clinical antagonists; skeptic validly challenges specific molecular intermediates (TRIM46) requiring replacement with better-characterized astrocytic actin regulators. EV-mediated transfer represents a more established but less novel pathway, while Miro1-mediated priming remains the weakest-linked hypothesis needing foundational validation.\"\n}\n```",
  "tokens_used": "887"
}